Related stories
Rhythm Pharmaceuticals Q3 Net Loss Narrows 22% to $41.37 Million
M impact | EQUITY | Nov 03, 2026, 12:20 PM UTC
Xometry Q3 Revenue Reaches $252.439 Million
Xometry reported Q3 revenue of $252.439 million versus an IBES estimate of $235.6 million.
M impact | EQUITY | Nov 03, 2026, 12:18 PM UTC
Xometry Gives Q4 Revenue Outlook
Xometry provided a fourth-quarter revenue outlook.
M impact | EQUITY | Nov 03, 2026, 12:09 PM UTC
Xometry Expects Q4 Revenue of $254M–$256M
M impact | EQUITY | Nov 03, 2026, 12:09 PM UTC
USA Compression Q3 Revenue Beats Estimates on Fleet Expansion, Higher Pricing
USA Compression reported third-quarter revenue above estimates, citing fleet expansion and higher pricing.
M impact | EQUITY | Nov 03, 2026, 12:09 PM UTC
OceanPact Agrees to Sell Two Offshore Support Vessels for USD 86 Million
OceanPact agreed to sell two offshore support vessels for USD 86 million.
M impact | EQUITY | Nov 03, 2026, 12:09 PM UTC